Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Gazzard

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Expert Review of Anti-Infective Therapy|April 7, 2006
HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitorsRachael Jones, Brian Gazzard
International Journal of STD & AIDS|August 24, 2006
The cost of antiretroviral drugs and influence on prescribing policiesRachael Jones, Brian Gazzard
Nature Reviews. Gastroenterology & Hepatology|August 27, 2009
Advances in sexually transmitted infections of the gastrointestinal tractSiew C Ng, Brian Gazzard
Lancet (London, England)|July 29, 2008
Risk of HIV transmission in discordant couplesGeoffrey P Garnett, Brian Gazzard
HIV Clinical Trials|April 14, 2009
Effects of first-line use of nucleoside analogues, efavirenz, and ritonavir-boosted protease inhibitors on lipid levelsAndrew Hill, Will Sawyer, Brian Gazzard
Postgraduate Medical Journal|July 11, 2007
Rights theory in a specific healthcare context: "speaking ill of the dead"Adrian Wildfire, Justin Stebbing, Brian Gazzard
The Journal of Infectious Diseases|March 18, 2006
The host control of lytic and latent infection with human herpesvirus-8Justin Stebbing, Brian Gazzard, Mark Bower
Current Topics in Medicinal Chemistry|October 8, 2003
Current treatment of HIV infectionSimon Portsmouth, Justin Stebbing, Brian Gazzard
The Journal of Antimicrobial Chemotherapy|April 2, 2003
How does HAART lead to the resolution of Kaposi's sarcoma?Justin Stebbing, Simon Portsmouth, Brian Gazzard
Applied Health Economics and Health Policy|June 21, 2011
Cost-efficacy analysis of the MONET trial using UK antiretroviral drug pricesBrian Gazzard, Andrew Hill, Anne Anceau
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Expert Review of Anti-Infective Therapy|April 7, 2006
HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitorsRachael Jones, Brian Gazzard
International Journal of STD & AIDS|August 24, 2006
The cost of antiretroviral drugs and influence on prescribing policiesRachael Jones, Brian Gazzard
Nature Reviews. Gastroenterology & Hepatology|August 27, 2009
Advances in sexually transmitted infections of the gastrointestinal tractSiew C Ng, Brian Gazzard
Lancet (London, England)|July 29, 2008
Risk of HIV transmission in discordant couplesGeoffrey P Garnett, Brian Gazzard
HIV Clinical Trials|April 14, 2009
Effects of first-line use of nucleoside analogues, efavirenz, and ritonavir-boosted protease inhibitors on lipid levelsAndrew Hill, Will Sawyer, Brian Gazzard
Postgraduate Medical Journal|July 11, 2007
Rights theory in a specific healthcare context: "speaking ill of the dead"Adrian Wildfire, Justin Stebbing, Brian Gazzard
The Journal of Infectious Diseases|March 18, 2006
The host control of lytic and latent infection with human herpesvirus-8Justin Stebbing, Brian Gazzard, Mark Bower
Current Topics in Medicinal Chemistry|October 8, 2003
Current treatment of HIV infectionSimon Portsmouth, Justin Stebbing, Brian Gazzard
The Journal of Antimicrobial Chemotherapy|April 2, 2003
How does HAART lead to the resolution of Kaposi's sarcoma?Justin Stebbing, Simon Portsmouth, Brian Gazzard
Applied Health Economics and Health Policy|June 21, 2011
Cost-efficacy analysis of the MONET trial using UK antiretroviral drug pricesBrian Gazzard, Andrew Hill, Anne Anceau
Pageof 21